Skip to content

SANUWAVE Health, Inc. SNWV Non-cash interest expense

Non-cash interest expense at other companies

ClearPoint Neuro logo
ClearPoint NeuroCLPT

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s non-cash interest expense?
SANUWAVE Health, Inc. (SNWV) reported non-cash interest expense of $57K in Q1 2026.
How has SANUWAVE Health, Inc.'s non-cash interest expense changed year-over-year?
SANUWAVE Health, Inc.'s non-cash interest expense decreased by 89.2% year-over-year, from $530K to $57K.
What is the long-term trend for SANUWAVE Health, Inc.'s non-cash interest expense?
Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s non-cash interest expense has grown at a -18.0% compound annual growth rate (CAGR), from $3.23M to $1.46M.